Venture - Series Unknown Pharmaceutical Companies

Jabez Biosciences develops clinical-stage cancer therapies, including small molecule drugs for solid and liquid tumors.

Revel Pharmaceuticals develops therapeutics for multiple diseases of aging including osteoarthritis, kidney, and complications of diabetes.

Cosmos Pharmaceuticals develops a solutions to combat prescription medication abuse and improve individualized patient care.

Oncostellae focuses on the discovery of new pharmaceutically active compounds and their development, from its initial phase

OWP Pharmaceuticals is a manufacturer and distributor of a range of epilepsy medications and ties up with nonprofits for patient support.

Dianosic aims at resolving patient compliance challenges in respiratory care with intranasal, drug-eluting, resorbable scaffolds

Sesh+ sells innovative risk-reduced nicotine products with a mission of eliminating tobacco related harm.

Mid-Atlantic BioTherapeutics is a Clinical-stage Pharmaceutical Company.

Redi.Health is a healthcare technology company that develops health management platform for patients.

OurPharma Holdings is a drug company that addresses the need for medications that are in short supply.

Halia Therapeutics is a biopharmaceutical company manufacturing therapies to improve the lives of patients with inflammatory disorders.

Nurocor provides a platform for digitized clinical development to help companies bring drugs to market faster.

Inventure develops medical imaging devices designed to detect the disease of the patients.

Synfini is a drug discovery platform combining AI, chemistry automation, and cloud tools to design improved molecules.

Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.

Cristcot focuses on drug delivery systems that combine products and specialty drug formulations.

Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates.

Paradigm Therapeutics is a biopharmaceutical company that develops therapies for rare diseases.

Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.

AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric surgery.

Innovacell is a biotechnology firm focused on cell-tissue therapy for the treatment of incontinence.

Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.

Zero Point Five Therapeutics develops drugs to treat soil-transmitted helminthiasis.

IAMA Therapeutics is a pharmaceutical business that develops novel therapeutics for unmet medical needs in the brain.

TIRmed Pharma develops drug candidates addressing major clinical needs.